Describing the epidemiology of COVID-19 in Nigeria: an analysis of the first year of the pandemic
File(s)OleribeTaylorRobinsonFinalCEPPR.pdf (608.68 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
We report the COVID-19 experience across Nigeria from March 2020 to March 2021. Demographics were obtained from Nigerian Center for Disease Control. By 21 March 2021, 161,737 people were confirmed positive for SARS-COV-2. Overall, testing rates were 0.8% of the population, with positivity rates of 9.6%, complete recovery rates without long-term sequelae of 91.4%, and case fatality rates of 1.3%. Most Nigerian regions contributed to figures for recent cases and deaths in 2021. The picture may change as testing is scaled-up to include community testing. Given so-called “pandemic fatigue” among the general population, various conspiracy theories being prevalent, and the recent introduction of COVID-19 vaccines in Nigeria, we assume that Nigeria is at a pivotal stage of the outbreak. Effort must be made by
government to learn successful strategies in other countries to adapt to prevent a rise in case numbers and deaths.
government to learn successful strategies in other countries to adapt to prevent a rise in case numbers and deaths.
Date Issued
2022-02-01
Date Acceptance
2021-04-27
Citation
Journal of Health Care for the Poor and Underserved, 2022, 33 (1), pp.33-46
ISSN
1049-2089
Publisher
Johns Hopkins University Press
Start Page
33
End Page
46
Journal / Book Title
Journal of Health Care for the Poor and Underserved
Volume
33
Issue
1
Copyright Statement
© Meharry Medical College
Subjects
COVID-19
COVID-19 Vaccines
Humans
Nigeria
Pandemics
SARS-CoV-2
Humans
Nigeria
Pandemics
COVID-19
SARS-CoV-2
COVID-19 Vaccines
Public Health
1117 Public Health and Health Services
Publication Status
Published